ID   SCSe004-A
AC   CVCL_B866
SY   MEL-4; Mel-4
DR   hPSCreg; SCSe004-A
DR   ISCR; 2228
DR   NIHhESC; NIHhESC-11-0142
DR   SKIP; SKIP002003
DR   Wikidata; Q54952668
RX   PubMed=28445466;
CC   From: Monash University; Melbourne; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0142.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-21.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=28445466; DOI=10.1038/nature22312;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative P53 mutations.";
RL   Nature 545:229-233(2017).
//